The Cytotoxic Effect of Eurycoma longifolia Jack Root Extract on The Prostate Adenocarcinoma PC-3 Cells through Apoptosis Enhancement
DOI:
https://doi.org/10.3889/oamjms.2020.4420Keywords:
Cytotoxic effect, Eurycoma longifolia Jack root, Apoptosis, Prostate adenocarcinomaAbstract
BACKGROUND: Prostate cancer is the second most common malignancy in men and has become the sixth leading cause of death in males worldwide. Eurycoma longifolia Jack root has active compounds, namely, quassinoids, eurycomanone, and canthine, which have potential as detoxicants, free radical antioxidants, and anticancer.
AIM: This study aimed to analyze the potential of the active compounds in E. longifolia Jack root in induce apoptosis in the prostate adenocarcinoma PC-3 cells.
METHODS: E. longifolia root active compounds were obtained by extracting them using ethanol solvent. The culture of prostate cancer PC-3 cell line was obtained from androgen-independent prostate adenocarcinoma with bone metastasis use as subject. Examination of the potency of E. longifolia root extract was conducted by observing the cells undergoing apoptosis with TUNEL assay.
RESULTS: One-way ANOVA test showed that the increase in apoptotic cells was associated proportionally with the concentration levels of E. longifolia root extract and showed a significant difference (α < 0.05).
CONCLUSION: The higher the dose of E. longifolia root extract, the higher will be the apoptotic level of adenocarcinoma cells PC3. E. longifolia extract is potentially used in the treatment of prostate cancer by inducing apoptotic mechanisms.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63-89. PMid:31068988
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi. org/10.3322/caac.21492 PMid:30207593
Umbas R, Hardjowijoto S, Mochtar CA, Safriady F, Djatisoesanto W, Soedarso MA, et al. Panduan penanganan kanker prostat. IAUI. 2011:1;1.
Rahman AS, Yap MM, Shakaff AY, Ahmad MN, Dahari Z, Ismail Z, et al. A microcontroller based taste sensing system for the verification of Eurycoma longifolia. Sens Actuators B. 2004;101(1-2):191-8. https://doi.org/10.1016/j.snb.2004.01.024
Ang HH. Cytotoxic and antimalarial constituents from the roots of Eurycoma longifolia. Fundam Clin Pharmacol. 2002;15:265-8.
Sangat HM, Zuhud EA, dan Damayanti EK. Kamus Penyakit dan Tumbuhan Obat Indonesia. Jakarta: Yayasan Obor Indonesia; 2000.
Ang HH, Hitotsuyanagi H, Fukaya H, Takeya K. Quassinoids from Eurycoma longifolia. Phytochemistry. 2002;59(8):833-7. https://doi.org/10.1016/s0031-9422(01)00480-0 PMid:11937162
Beddir AG, Ngwendson K. Eurycomaoside: A new quassinoid from the roots of Eurycoma longifolia. Chem Pharm Bull. 2003;51(11):1301-3. https://doi.org/10.1248/cpb.51.1301 PMid:14600377
Nurani LH, Pramono S, Mustofa M. The Cytotoxicity of Extract of Eurycoma longifolia Jack Root on T47D Cell Line, Proceeding. Yogyakarta: International Symposium, Cancer, Ahmad Dahlan University; 2008.
Tan HT, Raharja K. Obat-obat Penting: Khasiat, Penggunaan, dan Efek-Efek Sampingnya, Indonesia: PT Alex Media Komputindo Kelompok Gramedia; 2002. p. 810. https://doi. org/10.24198/farmasetika.v2i5.16780
Nurhanan MY, Hawairiah A, Ilham MA, Shukri M. Cytotoxic effects of the root extracts of Eurycoma longifolaia jack. Phytother Res. 2005;19(11):994-6. https://doi.org/10.1002/ ptr.1759 PMid:16317660
Choo CY, Chan KL. The toxicity of some quassinoids from Eurycoma longifolia. Planta Med. 2002;68(7):662-4. https://doi. org/10.1055/s-2002-32907 PMid:12143009
Ueda JY, Tezuka Y, Banskota AH, Tran QL, Harimaya Y, Saiki I, et al. Antiproliferative activity of Vietnamese medicinal plants. Biol Pharm Bull. 2002;25(6):753-60. https://doi.org/10.1248/ bpb.25.753 PMid:12081142
Alves IA, Miranda HM, Soares LA, Randau KP. Simaroubaceae family: Botany, chemical composition and biological activities. Rev Bras Farmacogn. 2014;24(4):481-501. https://doi. org/10.1016/j.bjp.2014.07.021
Rehman SU, Choe K, Yoo HH. Review on a traditional herbal medicine, Eurycoma longifolia jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules. 2016;21(3):331. https://doi.org/10.3390/ molecules21030331 PMid:26978330
Kuo PC, Damu AG, Lee KH, Wu TS. Cytotoxic and antimalarial constituents from roots of Eurycoma longifolia. Bioorg Med Chem. 2004;12(3):537-44. https://doi.org/10.1016/j. bmc.2003.11.017 PMid:14738962
Hajjouli S, Chateauvieux S, Teiten MH, Orlikova B, Schumacher M, Dicato M, et al. Eurycomanone and eurycomanol from Eurycoma longifolia jack as regulators of signaling pathways involved in proliferation, cell death and inflammation. Molecules. 2014;19(9):14649-66. https://doi. org/10.3390/molecules190914649 PMid:25230121
Jiwajinda S, Santisopasri V, Murakami A, Sugiyama H, Gasquet M, Riad E, et al. In vitro anti-tumor promoting and anti-parasitic activities of the quassinoids from Eurycoma longifolia, a medicinal plant in Southeast Asia. J Ethnopharmacol. 2002;82(1):55-8. https://doi.org/10.1016/ s0378-8741(02)00160-5 PMid:12169407
Miyake K, Tezuka Y, Awale S, Li F, Kadota S. Canthin-6-one alkaloids and a tirucallanoid from, Eurycoma longifolia and their cytotoxic activity against a human HT-1080 fibrosarcoma cell line. Nat Prod Commun. 2010;5(1):17-22. https://doi. org/10.1177/1934578x1000500105 PMid:20184012
Guo Z, Vangapandu S, Sindelar RW, Walker LA, Sindelar RD. Biologically active quassinoids and their chemistry: Potential leads for drug design. Curr Med Chem. 2005;12(2):173-90. https://doi.org/10.2174/0929867053363351 PMid:15638734
Rahman EY, Utomo DH, Ali M, Purnomo BB, Kania N. Evaluating the potency of active compounds from Eurycoma longifolia jack roots extract as prostate cancer therapy. Drug Invent Today. 2018;10(12):2374-7.
Goel RK, Singh D, Lagunin A, Poroikov V. PASS-assisted exploration of new therapeutic potential of natural products. Med Chem Res. 2011;20(9):509-1514. https://doi.org/10.1007/ s00044-010-9398-y
Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, et al. Apoptosis and cancer: Mutations within caspase genes. J Med Genet. 2009;46(8):497-510. https://doi. org/10.1136/jmg.2009.066944 PMid:19505876
Powell CB, Fung P, Jackson J, Dall’Era J, Lewkowicz D, Cohen I, et al. Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer induces apoptosis of ovarian cancer cell lines. Gynecol Oncol. 2009;91(2):332-40. https://doi.org/10.1016/j.ygyno.2003.07.004 PMid:14599863
Alshatwi AA, Shafi G, Hasan TN, Al-Hazzani A, Alsaif MA. Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract. Asian Pac J Cancer Prev. 2011;12(6):1555-9. PMid:22126498
Zhang MC, Liu HP, Demchik LL, Zhai YF, Yang DJ. Light sensitizes IFN-gamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways. Cell Res. 2004;14(2):117-24. https://doi.org/10.1038/ sj.cr.7290210 PMid:15115612
Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, Kwon JT. Small molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol. 2006;2(10):543-50. https://doi.org/10.1038/nchembio814 PMid:16936720
Nurkhasanah M, Azimahtol HL. Eurycomanone induces apoptosis through the up-regulation of p53 in human cervical carcinoma cells. J Cancer Mol. 2008;4(4):109-15.
Downloads
Published
How to Cite
License
Copyright (c) 2020 Eka Yudha Rahman, Kusworini Kusworini, Mulyohadi Ali, Basuki Bambang Purnomo, Nia Kania (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0